Home > National Drug Code (NDC) > Somatuline Depot

Somatuline Depot - 15054-0120-1 - (lanreotide acetate)

Alphabetical Index


Drug Information of Somatuline Depot

Product NDC: 15054-0120
Proprietary Name: Somatuline Depot
Non Proprietary Name: lanreotide acetate
Active Ingredient(s): 120    mg/.5mL & nbsp;   lanreotide acetate
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Somatuline Depot

Product NDC: 15054-0120
Labeler Name: Ipsen Biopharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022074
Marketing Category: NDA
Start Marketing Date: 20071114

Package Information of Somatuline Depot

Package NDC: 15054-0120-1
Package Description: 1 POUCH in 1 CARTON (15054-0120-1) > 1 SYRINGE in 1 POUCH > .5 mL in 1 SYRINGE

NDC Information of Somatuline Depot

NDC Code 15054-0120-1
Proprietary Name Somatuline Depot
Package Description 1 POUCH in 1 CARTON (15054-0120-1) > 1 SYRINGE in 1 POUCH > .5 mL in 1 SYRINGE
Product NDC 15054-0120
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name lanreotide acetate
Dosage Form Name INJECTION
Route Name SUBCUTANEOUS
Start Marketing Date 20071114
Marketing Category Name NDA
Labeler Name Ipsen Biopharmaceuticals, Inc.
Substance Name LANREOTIDE ACETATE
Strength Number 120
Strength Unit mg/.5mL
Pharmaceutical Classes Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]

Complete Information of Somatuline Depot


General Information